Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Selective orexin 2 receptor antagonism blocks cue-induced reinstatement, but not nicotine self-administration or nicotine-induced reinstatement
Jason M. Uslaner, Christopher J. Winrow, Anthony L. Gotter, et al.
Behavioural Brain Research (2014) Vol. 269, pp. 61-65
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

A Decade of Orexin/Hypocretin and Addiction: Where Are We Now?
Morgan H. James, Stephen V. Mahler, David E. Moorman, et al.
Current topics in behavioral neurosciences (2016), pp. 247-281
Closed Access | Times Cited: 169
Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia
Anthony J. Roecker, Christopher D. Cox, Paul J. Coleman
Journal of Medicinal Chemistry (2015) Vol. 59, Iss. 2, pp. 504-530
Closed Access | Times Cited: 107
Orexins and fear: implications for the treatment of anxiety disorders
África Flores, Rocío Saravia, Rafaël Maldonado, et al.
Trends in Neurosciences (2015) Vol. 38, Iss. 9, pp. 550-559
Open Access | Times Cited: 92
Intermittent self‐administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system
Jennifer E. Fragale, Morgan H. James, Gary Aston‐Jones
Addiction Biology (2020) Vol. 26, Iss. 3
Open Access | Times Cited: 65
Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors
F. Woodward Hopf
Neuropharmacology (2020) Vol. 168, pp. 108013-108013
Open Access | Times Cited: 50
Targeting the orexin/hypocretin system for the treatment of neuropsychiatric and neurodegenerative diseases: From animal to clinical studies
Marc Ten-Blanco, África Flores, Luigia Cristino, et al.
Frontiers in Neuroendocrinology (2023) Vol. 69, pp. 101066-101066
Open Access | Times Cited: 19
Orexin-A/Hypocretin-1 Mediates Cocaine-Seeking Behavior in the Posterior Paraventricular Nucleus of the Thalamus via Orexin/Hypocretin Receptor-2
Alessandra Matzeu, Tony M. Kerr, Friedbert Weiss, et al.
Journal of Pharmacology and Experimental Therapeutics (2016) Vol. 359, Iss. 2, pp. 273-279
Open Access | Times Cited: 60
Hypocretins, Neural Systems, Physiology, and Psychiatric Disorders
Shi‐Bin Li, Jeff R. Jones, Luı́s de Lecea
Current Psychiatry Reports (2016) Vol. 18, Iss. 1
Closed Access | Times Cited: 59
Orexin/Hypocretin System: Role in Food and Drug Overconsumption
Jessica R. Barson, Sarah F. Leibowitz
International review of neurobiology (2017), pp. 199-237
Open Access | Times Cited: 56
Drug addiction: An affective-cognitive disorder in need of a cure
Liana Fattore, Marco Diana
Neuroscience & Biobehavioral Reviews (2016) Vol. 65, pp. 341-361
Closed Access | Times Cited: 49
Understanding the Role of Orexin Neuropeptides in Drug Addiction: Preclinical Studies and Translational Value
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Behavioral Neuroscience (2022) Vol. 15
Open Access | Times Cited: 26
Drug Seeking and Relapse: New Evidence of a Role for Orexin and Dynorphin Co-transmission in the Paraventricular Nucleus of the Thalamus
Alessandra Matzeu, Rémi Martin‐Fardon
Frontiers in Neurology (2018) Vol. 9
Open Access | Times Cited: 35
Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior
Natalie E. Zlebnik, Nathan A. Holtz, Victoria C. Lepak, et al.
Drug and Alcohol Dependence (2021) Vol. 224, pp. 108719-108719
Open Access | Times Cited: 24
Alternative use of suvorexant (Belsomra®) for the prevention of alcohol drinking and seeking in rats with a history of alcohol dependence
Francisco J. Flores‐Ramirez, Jessica M. Illenberger, Glenn Pascasio, et al.
Frontiers in Behavioral Neuroscience (2022) Vol. 16
Open Access | Times Cited: 16
Suvorexant, an FDA-approved dual orexin receptor antagonist, reduces oxycodone self-administration and conditioned reinstatement in male and female rats
Jessica M. Illenberger, Francisco J. Flores‐Ramirez, Alessandra Matzeu, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 9
Orexin-mediated Motivated Arousal and Reward Seeking.
Theresa E. Bjorness, Robert Greene
Peptides (2024) Vol. 180, pp. 171280-171280
Closed Access | Times Cited: 3
Targeting the orexin system for prescription opioid use disorder: Orexin-1 receptor blockade prevents oxycodone taking and seeking in rats
Alessandra Matzeu, Rémi Martin‐Fardon
Neuropharmacology (2019) Vol. 164, pp. 107906-107906
Open Access | Times Cited: 28
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
Mark K. Greenwald, Tabitha E.H. Moses, Timothy Roehrs
Translational research (2021) Vol. 234, pp. 58-73
Open Access | Times Cited: 20
Blockade of orexin receptors in the infralimbic cortex prevents stress‐induced reinstatement of alcohol‐seeking behaviour in alcohol‐dependent rats
Francisco J. Flores‐Ramirez, Florence P. Varodayan, Reesha R. Patel, et al.
British Journal of Pharmacology (2022) Vol. 180, Iss. 11, pp. 1500-1515
Open Access | Times Cited: 15
Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders
Hiroshi Tsuneki, Tsutomu Wada, Toshiyasu Sasaoka
Pharmacology & Therapeutics (2017) Vol. 186, pp. 25-44
Closed Access | Times Cited: 28
Neurobiological and Neurophysiological Mechanisms Underlying Nicotine Seeking and Smoking Relapse
Heath D. Schmidt, Laura E. Rupprecht, Nii Addy
Complex Psychiatry (2018) Vol. 4, Iss. 4, pp. 169-189
Open Access | Times Cited: 25
Blockade of corticotropin-releasing factor-1 receptors in the infralimbic cortex prevents stress-induced reinstatement of alcohol seeking in male Wistar rats: Evidence of interaction between CRF1 and orexin receptor signaling
Francisco J. Flores‐Ramirez, Alessandra Matzeu, Laura Sánchez‐Marín, et al.
Neuropharmacology (2022) Vol. 210, pp. 109046-109046
Open Access | Times Cited: 13
Distinct roles for orexin-1 and orexin-2 receptors in the dentate gyrus of the hippocampus in the methamphetamine-seeking behavior in the rats
Farzaneh Nazari-Serenjeh, Ronak Azizbeigi, Mina Rashvand, et al.
Life Sciences (2022) Vol. 312, pp. 121262-121262
Closed Access | Times Cited: 13
Neurobiological Bases of Cue- and Nicotine-induced Reinstatement of Nicotine Seeking: Implications for the Development of Smoking Cessation Medications
Astrid K. Stoker, Athina Markou
Current topics in behavioral neurosciences (2015), pp. 125-154
Closed Access | Times Cited: 21
Neuroanatomical Relationships between Orexin/Hypocretin-Containing Neurons/Nerve Fibers and Nicotine-Induced c-Fos-Activated Cells of the Reward-Addiction Neurocircuitry
Ozra Dehkordi, Jed E. Rose, Martha I. Dávila‐García, et al.
Journal of Alcoholism and Drug Dependence (2017) Vol. 05, Iss. 04
Open Access | Times Cited: 20
Page 1 - Next Page

Scroll to top